hide message

A message from Executive Director Phil Bloomer

Now more than ever, advocates in NGOs and business need the information we provide to continue to put human rights at the centre of business.

We are a small non-profit with a huge mission. We can only provide our global coverage and Weekly Updates with donations from people like you.

Please consider contributing to our work today. No gift is too small!

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Aurobindo Pharmaceuticals

🔎 Run a search for “Aurobindo Pharmaceuticals”

Get RSS feed of these results

All stories

Story
13 February 2017

India: 2017 Responsible Business Index ranks top 100 listed companies

In an attempt to gauge how Indian firms are coping with the interests of various stakeholders, a collaborative effort of non-profits—Oxfam India, Corporate Responsibility Watch, Praxis and Partners in Change—has put together the second edition of...

See full story

Article
17 July 2015

India: Tergene Biotech develops affordable pneumonia vaccine

Author: M Somasekhar, Hindu (India)

"Tergene Biotech develops vaccine to combat pneumonia", 16 Jul 2015...

Read more

Story
9 October 2008

Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions

See full story

Article
9 October 2008

Secretary-General's statement following meeting with pharmaceutical and diagnostic companies working on HIV and AIDS

Author: United Nations

I met today with senior executives of seventeen of the world's research-based and generic pharmaceutical and diagnostic companies…to review progress on...expand[ing] access to HIV prevention, treatment, care and support services in low- and middle...

Read more

Article
29 April 2008

Deal lowers price of second-line therapy and makes new paediatric formulations available to poorer countries

Author: Michael Carter, Aidsmap

Further reductions in the prices of generic versions of key second-line antiretroviral drugs were announced yesterday, thanks to an agreement negotiated by the international drug purchase fund UNITAID and the Clinton HIV/AIDS Initiative with Indian...

Read more

Article
10 August 2007

Cipla quarrels with AIDS activists on price of drug

Author: Marc Iskowitz, Medical Marketing & Media

The AIDS Healthcare Foundation...mounted a new advocacy campaign yesterday challenging Cipla for an alleged price disparity between what the firm charges for its generic drugs in India vs. Africa. Cipla refuted the over-pricing charges in ads of its...

Read more

Article
31 May 2007

Boehringer offers HIV drug without patents

Author: Bhuma Shrivastava, Mint [India]

...Boehringer Ingelheim has decided not to enforce patents on its anti-HIV drug, Nevirapine, in 78 low-income African and Asian countries...In a statement on its website, Boehringer says it will issue “short, non-assert declarations”, or licences, to...

Read more

Story
30 November 2006

Cipla, Ranbaxy to cut paediatric antiretroviral drug prices to as low as $60/year for poor countries ahead of World AIDS Day under deal with Clinton Foundation

See full story

Article
30 November 2006

President Clinton Announces Breakthroughs in HIV/AIDS Treatment for Children— 3-in-1 Pill for less than $60 Annually and 45% Price Reductions for other Pediatric Drugs

Author: Clinton Foundation [USA]

President Bill Clinton announced today that his foundation has negotiated new agreements to lower the price of HIV/AIDS treatment for children. Cipla and Ranbaxy will price a new child-friendly product...for less than $60 per year... The new prices...

Read more

Article
25 September 2006

Indian Firms to Make HIV Drug - Gilead Sciences licenses AIDS treatment Tenofovir to eight more Indian companies

Author: Red Herring [USA]

Eight more Indian companies have received nonexclusive licenses from Gilead Sciences to manufacture and distribute the HIV drug Tenofovir...The [eight] Indian drug companies that struck the licensing deal were [Ranbaxy Laboratories], Aurobindo Pharma,...

Read more